Holders over time
Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
- KRYS
- ARGX
| Quarter | KRYS | ARGX |
|---|---|---|
| Q3 2020 | 4 holders, $52m | 8 holders, $3.6bn |
| Q4 2020 | 3 holders, $66m | 7 holders, $4.1bn |
| Q1 2021 | 3 holders, $67m | 8 holders, $4.1bn |
| Q2 2021 | 2 holders, $28m | 9 holders, $4.6bn |
| Q3 2021 | 2 holders, $31m | 8 holders, $4.5bn |
| Q4 2021 | 2 holders, $135m | 9 holders, $5.3bn |
| Q1 2022 | 1 holders, $114m | 8 holders, $5.3bn |
| Q2 2022 | 2 holders, $107m | 13 holders, $6.5bn |
| Q3 2022 | 3 holders, $97m | 14 holders, $5.3bn |
| Q4 2022 | 3 holders, $59m | 13 holders, $5.5bn |
| Q1 2023 | 3 holders, $59m | 13 holders, $5.9bn |
| Q2 2023 | 3 holders, $82m | 18 holders, $6.6bn |
| Q3 2023 | 5 holders, $143m | 21 holders, $8.7bn |
| Q4 2023 | 5 holders, $109m | 17 holders, $6.3bn |
| Q1 2024 | 8 holders, $853m | 13 holders, $6.8bn |
| Q2 2024 | 6 holders, $1.0bn | 14 holders, $7.9bn |
| Q3 2024 | 5 holders, $976m | 13 holders, $10.7bn |
| Q4 2024 | 5 holders, $850m | 14 holders, $12.3bn |
| Q1 2025 | 5 holders, $993m | 17 holders, $11.8bn |
| Q2 2025 | 4 holders, $746m | 18 holders, $10.8bn |
| Q3 2025 | 5 holders, $938m | 16 holders, $13.8bn |
| Q4 2025 | 7 holders, $1.4bn | 16 holders, $14.8bn |
| Q1 2026 | 6 holders, $1.5bn | 11 holders, $12.3bn |
| Q2 2026 | 6 holders, $2.4bn | 14 holders, $15.0bn |
KRYS
Krystal Biotech Inc
- Holders
- 6
- Reported value
- $2.4bn
- Buyers
- 12
- Sellers
- 14
Breadth -2 among 91 comparable managers.
ARGX
Argenx Se
- Holders
- 14
- Reported value
- $15.0bn
- Buyers
- 16
- Sellers
- 15
Breadth +1 among 91 comparable managers.
Who holds both, Q2 2026
Among the 15 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.